Results

Total Results: 1,161 records

Showing results for "patient safety".

  1. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_2012-12-11.pdf
    January 01, 2012 - data and postmarket safety evaluation—set forth by the U.S. … Kushner and colleagues announced results from a phase III clinical trial (SEQUEL) evaluating the safety … However, a potential increase in per-patient cost might serve as a barrier to acceptance by some patients … While preliminary results are promising, further studies evaluating efficacy and safety are needed, … Safety and efficacy study of EndoBarrier in subjects with type II diabetes and obesity.
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-web-interactive-presentation.pdf
    September 01, 2019 - Associate Chief Medical Officer for Patient Safety and Clinical Quality Assistant Professor of Medicine … with urinary incontinence, as well as health system decisions related to improving patient safety and … We engaged the Associate Chief Medical Officer (CMO) for Patient Safety and Clinical Quality and the … The Associate Chief CMO for Patient Safety and Clinical Quality is tasked with setting Duke’s quality … agenda and coordinating patient safety and clinical quality activities across the Duke Health System
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-208-bipolar-evidence-summary.pdf
    August 01, 2018 - Future research should also enroll people with different patient characteristics and initial episodes … Are bipolar II patients cognitively impaired? A systematic review. … Efficacy and safety of olanzapine in the treatment of Japanese patients with bipolar I disorder in … A randomized, double- blind, placebo-controlled efficacy and safety study of quetiapine or lithium as … Treatment in a specialised out-patient mood disorder clinic v. standard out-patient treatment in the
  4. effectivehealthcare.ahrq.gov/sites/default/files/diabetes-update-2015_disposition-comments.pdf
    January 01, 2015 - We removed the word safety from the title for Table D. … We have discussed patient preference as well as cost briefly as potential drivers. … Efficacy and safety of the once-weekly GLP-1 receptor agonist albiglutide versus sitagliptin in patients … varies with patient characteristics. … 16 patients 0.2 in the placebo group P 0.42 definite acute pancreatitis in 17 patients 0.2 and 9 patients
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/vaccine-safety_research-protocol.pdf
    September 18, 2012 - System (VAERS),11 the Vaccine Safety Datalink,12 and the Clinical Immunization Safety Assessment Network … Both patient factors (i.e., age and race) and vaccine factors (i.e., formulation, dosage, and timing … AEs) or passive (participants are not specifically asked about or tested for the occurrence of AEs; patient … Multiple publications are defined by the investigated patients. F. … The Vaccine Safety Datalink: a model for monitoring immunization safety.
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3_0.pdf
    May 01, 2022 - The pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with … Pharmacokinetics, Safety, and Tolerability of a Medicinal Cannabis Formulation in Patients with Chronic … Efficacy, tolerability and safety of cannabinoids for management of pain in adult patients with multiple … Marijuana, Lower Urinary Tract Symptoms, and Pain in the Urologic Patient. … Care of the Patient Using Cannabis.
  7. Diabetes Mellitus (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1412.pdf
    January 01, 2015 - 7% by week 39. 9 The safety and efficacy of the ITCA 650 pump system compared with twice-daily … Summary of safety and effectiveness data (SSED). MiniMed 530G system. P120010. … Important safety information: Animas Vibe insulin pump and CCGM system. [internet]. … Available: http://www.animas.com/safety. 27. … A study of the safety and efficacy of a new treatment for diabetic macular edema.
  8. effectivehealthcare.ahrq.gov/sites/default/files/methods-report-web-interactive-presentation-appendix-a.pdf
    May 29, 2025 - Bae, MD: Associate Chief Medical Officer for Patient Safety and Clinical Quality • G.
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/skin-lesions-evaluation_research-protocol.pdf
    August 23, 2010 - What are the potential safety issues and harms associated with the use of non-invasive diagnostic techniques … Guiding question 3: What published and unpublished studies have reported on the use and safety of these … Provide a synthesis of the following information: i Indication/patient inclusion criteria ii Type … of techniques/modalities iii Study design and size iv Role of the test in patient management v … Strategies for early melanoma detection: Approaches to the patient with nevi.
  10. Diabetes Mellitus (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1312.pdf
    January 01, 2016 - Patients and their diabetes care team work to adjust patient insulin dosages using feedback from a … complications would lower long-term, per-patient costs for both patients and third- party payers. … Genentech has a patient-assistance program to help defray costs for qualified patients.175 Several … affecting patient acceptance. … Efficacy, safety, and tolerability of exenatide once weekly in patients with type 2 diabetes mellitus
  11. Diabetes Mellitus (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1306.pdf
    January 01, 2016 - But the experts called for longer safety and efficacy studies to determine whether this system would … Genentech has a patient assistance program to help defray costs for qualified patients.135 Several … Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to … Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used … Efficacy, safety, and tolerability of exenatide once weekly in patients with type 2 diabetes mellitus
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/prioritization-selection-of-harms.pdf
    February 01, 2018 - http://www.fda.gov/Safety/MedWatch/HowToReport/ucm053087.htm http://www.fda.gov/Safety/MedWatch/HowToReport … 9) How should input from technical and clinical experts and patients or patient advocacy groups be used … How should input from technical and clinical experts and patients or patient advocacy groups be used … Had to report data from groups of in which at least 85% of the patients were from one of the patient … What are the harms of therapeutic interventions for patients with ME/CFS and how do they vary by patient
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-treatment_research-protocol.pdf
    September 29, 2011 - What are the significant safety concerns associated with each treatment strategy (i.e., adverse drug … What are the significant safety concerns associated with each treatment strategy (i.e., adverse drug … What are the significant safety concerns associated with each treatment strategy (i.e., adverse drug … volume, setting, guideline-based treatment protocols) Safety and adverse effects, including … The safety outcomes will be framed to help identify adverse events, including adverse drug reactions
  14. effectivehealthcare.ahrq.gov/sites/default/files/04_dementia_potential_high_impact_june_2012.pdf
    January 01, 2012 - On the other hand, some thought that knowing that a patient has AD could aid planning in terms of safety … and care of the patient … and care of the patient. … A diagnosis could, however, aid patients and families in planning for the patient’s care and safety. … AD patients.
  15. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/obesity_hi_impact.pdf
    April 17, 2012 - data and postmarket safety evaluation, set forth by the U.S. … FDA expressed concerns about the long-term cardiovascular safety profile in the overweight and obese … Experts also opined that further studies evaluating efficacy and safety are needed. … quality of life, thus impacting patient health outcomes. … Safety and efficacy study of EndoBarrier in subjects with type II diabetes and obesity.
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/patient-navigation-model-lung-cancer-rapid.pdf
    December 01, 2018 - Eight categories of navigation activities provided in studies including: • Screening education • Client … transport • Ongoing barriers counseling • Teaching test instructions Minority FQHC clients 6 … review, electronic client database, or referral by provider. 7 Study Information Author … among a racially diverse, medically underserved population served by a safety-net health system. … Patient navigation for lung cancer screening in an urban safety-net system: Protocol for a pragmatic
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/psychiatric-readmissions_research-protocol.pdf
    December 31, 2014 - demographics, diagnosis, and coexisting conditions; and specific harms or safety issues? … demographics, diagnosis, and coexisting conditions; and specific harms or safety issues? … demographics, diagnosis, and coexisting conditions; and specific harms or safety issues? … Search terms Search Query Items found #1 Search ("Patient Admission"[Mesh] OR "Patient Discharge" … "[All Fields] OR "Patient Readmission"[Mesh] OR "brief admission"[All Fields] OR "patient admission
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoporosis-vibration-therapy_research-protocol.pdf
    January 01, 2020 - When should patient outcomes be measured (length of followup)? … Questions for Clinicians, Patients, and Patient Advocates. a. … vibration (effectiveness, safety, FDA approval, doctor recommendation, other)? … Upper gastrointestinal tract safety of risedronate: a pooled analysis of 9 clinical trials. … Population Country of residence of patients Inclusion criteria Exclusion criteria Number of patients
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-2007_research-2007-1.pdf
    January 01, 2007 - For adult patients with essential hypertension, how do ACEIs and ARBs differ in safety, adverse events … For adult patients with essential hypertension, how do ACEIs and ARBs differ in safety,d adverse events … For adult patients with essential hypertension, how do ACEIs and ARBs differ in safety, adverse events … For adult patients with essential hypertension, how do ACEIs and ARBs differ in safety,d adverse events … Many of the studies reported limited data on patient characteristics, and black patients appeared to
  20. effectivehealthcare.ahrq.gov/sites/default/files/ch_8-user-guide-to-ocer_130129.pdf
    October 01, 2013 - ablation for hepatocellular carcinoma compared to resection or no treatment5 and a comparison of the safety … missing biochemistry lab data compared to early-stage patients (6-9% incomplete in early-stage patients … linked to Medicare claims, are a valuable resource that has generated comparative effectiveness and safety … Comparative assessment of the safety and effectiveness of radiofrequency ablation among elderly Medicare … Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: